Evelyn Lee
Academic
 | Dr Evelyn Lee Contact Details |
Evelyn is a health economist at the Centre for Economic Impacts of Genomic Medicine. She completed her PhD in Economics from the University of New South Wales (UNSW Sydney). She holds a Macquarie University Research Fellowship focusing on the economic burden of substance misuse. Her expertise is in dynamic simulation modelling to assess the impact - cost, and equity of different combinations of policies and interventions in a virtual world before they are applied to the real-world settings.
Evelyn serves as a member of the NSW Population and Health Service Research Ethics Committee (PHSREC) and is an associate editor for Addiction, Scientific Reports and Paediatrics and Child Health.
She read Economics at the National University of Singapore and is a visiting fellow at York University, UK.
Selected Publications
Loe, M. W. C., Soenong, H., Lee, E., et al. Nirsevimab: Alleviating the burden of RSV morbidity in young children. (2024) Journal of Paediatrics and Child Health. Published online 24 August 2024. https://onlinelibrary.wiley.com/doi/full/10.1111/jpc.16643
Lee E, Schofield D, Dronavalli M, et al. Health Care Needs and Costs for Children Exposed to Prenatal Substance Use to Adulthood. JAMA Pediatrics. Published online July 22, 2024. doi:10.1001/jamapediatrics.2024.2281 https://jamanetwork.com/journals/jamapediatrics/fullarticle/2821473
Uebel, H., Dronavalli, M., Lawler, K., Lee, E., et al. School performance in children with prenatal drug exposure and out-of-home care in NSW, Australia: a retrospective population-based cohort study. The Lancet Child & Adolescent Health. 2024 8(7), 500-509. https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(24)00076-2/abstract
Lawler K, Dronavalli M, Page A, Lee E, et al. Joining the Dots: Linking Prenatal Drug Exposure to Childhood and Adolescence–research protocol of a population cohort study. BMJ Paediatrics Open 8.1 (2024) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11015252/
*Schofield D, *Lee E, Parmar J, et al. Economic evaluation of population-based, expanded reproductive carrier screening for genetic diseases in Australia. Genetics in Medicine. 2023;25(5):100813. https://doi.org/10.1016/j.gim.2023.100813
*Shared co-first authorship
Lee E, Zhang J. Which assisted reproductive technology (ART) treatment strategy is the most clinically and cost-effective for women of advanced maternal age: a Markov model. BMC Health Services Research. 2022;22(1):1197. https://doi.org/10.1186/s12913-022-08485-2
Lee, E., Schofield, D., Owens, C. E., & Oei, J. L. (2022, June). An economic analysis of the cost of survival of micro preemies: A systematic review. In Seminars in Fetal and Neonatal Medicine (Vol. 27, No. 3, p. 101336). WB Saunders https://doi.org/10.1016/j.siny.2022.101336
Inekwe JN, Lee E. Perceived social support on postpartum mental health: An instrumental variable analysis. Plos one. 2022;17(5):e0265941. https://doi.org/10.1371/journal.pone.0265941
Lee E, Mao L, de Wit J, et al. Impact of the removal of patient co-payments for antiretroviral therapy (ART) on out-of-pocket expenditure, adherence and virological failure among Australian adults living with HIV. Health policy. 2021;125(9):1131-1139. https://doi.org/10.1016/j.healthpol.2021.07.002
Lee E, Schofield D, Azim SI, Oei JL. Economic evaluation of interventions for treatment of neonatal opioid withdrawal syndrome: A review. Children. 2021;8(7):534. https://doi.org/10.3390/children8070534
Oei J L, Azim S I, Lee E, Blythe S, et al. Substance use during pregnancy, birth and the postnatal period: an Evidence Check rapid review brokered by the Sax Institute (www.saxinstitute.org.au) NSW Ministry of Health, January 2021 https://www.saxinstitute.org.au/evidence-check/substance-use-during-pregnancy-birth-and-the-postnatal-period/
Lee E, Costello MF, Botha WC, Illingworth P, Chambers GM. A cost‐effectiveness analysis of preimplantation genetic testing for aneuploidy (PGT‐A) for up to three complete assisted reproductive technology cycles in women of advanced maternal age. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2019;59(4):573-579. https://doi.org/10.1111/ajo.12988
Lee, E., Illingworth, P., Wilton, L., & Chambers, G. M. (2015). The clinical effectiveness of preimplantation genetic diagnosis for aneuploidy in all 24 chromosomes (PGD-A): systematic review. Human Reproduction, 30(2), 473-483. https://doi.org/10.1093/humrep/deu303
Chambers, G. M., Lee, E., Hoang, V. P., Hansen, M., Bower, C., & Sullivan, E. A. (2014). Hospital utilization, costs and mortality rates during the first 5 years of life: a population study of ART and non-ART singletons. Human reproduction, 29(3), 601-610. https://doi.org/10.1093/humrep/det397
Chambers, G. M., Hoang, V. P., Lee, E., Hansen, M., Sullivan, E. A., Bower, C., & Chapman, M. (2014). Hospital costs of multiple-birth and singleton-birth children during the first 5 years of life and the role of assisted reproductive technology. JAMA pediatrics, 168(11), 1045-1053. DOI: 10.1001/jamapediatrics.2014.1357
Holt M, Lea T,.. Lee E,. et al. Community-level changes in condom use and uptake of HIV pre-exposure prophylaxis by gay and bisexual men in Melbourne and Sydney, Australia: results of repeated behavioural surveillance in 2013–17. The Lancet HIV. 2018;5(8):e448-e456. DOI: 10.1016/S2352-3018(18)30072-9
Holt M, Lee E, Lea T, et al. HIV preexposure prophylaxis cascades to assess implementation in Australia: results from repeated, national behavioral surveillance of gay and bisexual men, 2014–2018. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2020;83(3):e16-e22. DOI: 10.1097/QAI.0000000000002243
Lee E, Chambers GM, Hale L, Illingworth P, Wilton L. Assisted reproductive technology (ART) cumulative live birth rates following preimplantation genetic diagnosis for aneuploidy (PGD‐A) or morphological assessment of embryos: A cohort analysis. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2018;58(5):525-532. https://doi.org/10.1111/ajo.12756
Hah JM, Lee E, Shrestha R, et al. Return to work and productivity loss after surgery: a health economic evaluation. International Journal of Surgery. 2021;95:106100. https://doi.org/10.1016/j.ijsu.2021.106100
Grants and Funding
2023: CHE (York) - Visiting Scholar.
2022-2025: Lungs for life. Virtual ward to improve outcomes of infants with bronchopulmonary dysplasia (BPD) MRFF Grant ($1,918,884), CI (Lead, economic outcome using data linkage)
2021: Macquarie University Research Fellowship. Recipient.
2021: Evidence check: Substance use during pregnancy, birth and the postnatal period, NSW Sax Institute ($40,000), (Lead, review of economic evidence)
2021: Application of Artificial Intelligence for mental healthcare: Proof of concept study. MQBS Grant Accelerator Scheme ($10,000) Lead CI.
2019-2023: Expanding Access to Addiction Medicine Specialists care in Non-Metropolitan Regions of NSW: The Hub Project Evaluation: NSW Translational Research Grants Scheme (TRGS) ($503,724), CI (Lead, economic outcome of Hub project)